Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01480154
Title Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

renal cell carcinoma

prostate cancer

Advanced Solid Tumor

kidney cancer

melanoma

Therapies

Hydroxychloroquine + MK2206

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.